Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both CombinedJ. Lundgren, Signe S. Torekov, Jens‐Erik Beck Jensen et al.|New England Journal of Medicine|2021Cited by 469
GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese WomenEva W. Iepsen, Signe S. Torekov, J. Lundgren et al.|The Journal of Clinical Endocrinology & Metabolism|2015Cited by 187
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trialRasmus Michael Sandsdal, Signe S. Torekov, Christian R. Juhl et al.|Cardiovascular Diabetology|2023Cited by 157
Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination TreatmentSimon Birk Kjær Jensen, Signe S. Torekov, Victor Sørensen et al.|JAMA Network Open|2024Cited by 109
A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture RiskSigne S. Torekov, Bente Langdahl, Lars Rejnmark et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 107